The emerging roles of liver X receptors and their ligands in cancer

Bibliography

• Song C, Hiipakka RA, Kokontis JM, et al. Ubiquitous receptor: structures, immunocytochemical localization, and modulation of gene activation by receptors for retinoic acids and thyroid hormones. Ann N Y Acad Sci 1995;761:38-49
   PubMed Web of Science ®Google Scholar
• Shinar DM, Endo N, Rutledge SJ, et al. NER, a new member of the gene family encoding the human steroid hormone nuclear receptor. Gene 1994;147(2):273-6
   PubMed Web of Science ®Google Scholar
• Teboul M, Enmark E, Li Q, et al. OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor. Proc Natl Acad Sci USA 1995;92(6):2096-100
   PubMed Web of Science ®Google Scholar
• Nuclear Receptors Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999;97(2):161-3
   PubMed Web of Science ®Google Scholar
• Seol W, Choi HS, Moore DD. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol Endocrinol 1995;9(1):72-85
   PubMed Web of Science ®Google Scholar
• Apfel R, Benbrook D, Lernhardt E, et al. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol Cell Biol 1994;14(10):7025-35
   PubMed Web of Science ®Google Scholar
• Willy PJ, Umesono K, Ong ES, et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 1995;9(9):1033-45
   PubMed Web of Science ®Google Scholar
• Wrange O, Gustafsson JA. Separation of the hormone- and DNA-binding sites of the hepatic glucocorticoid receptor by means of proteolysis. J Biol Chem 1978;253(3):856-65
   PubMed Web of Science ®Google Scholar
• Weinberger C, Hollenberg SM, Rosenfeld MG, et al. Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product. Nature 1985;318(6047):670-2
   PubMed Web of Science ®Google Scholar
• Kumar V, Green S, Staub A, et al. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. Embo J 1986;5(9):2231-6
   PubMed Web of Science ®Google Scholar
• Janowski BA, Willy PJ, Devi TR, et al. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996;383(6602):728-31
   PubMed Web of Science ®Google Scholar
• Janowski BA, Grogan MJ, Jones SA, et al. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci USA 1999;96(1):266-71
   PubMed Web of Science ®Google Scholar
• Swahn BM, Macsari I, Viklund J, et al. Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides. Bioorg Med Chem Lett 2009;19(7):2009-12
   PubMed Web of Science ®Google Scholar
• Hu B, Unwalla R, Collini M, et al. Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta. Bioorg Med Chem 2009;17(10):3519-27
   PubMed Web of Science ®Google Scholar
• Plat J, Nichols JA, Mensink RP. Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation. J Lipid Res 2005;46(11):2468-76
   PubMed Web of Science ®Google Scholar
• Berrodin TJ, Shen Q, Quinet EM, et al. Identification of 5alpha, 6alpha-epoxycholesterol as a novel modulator of liver X receptor activity. Mol Pharmacol 2010;78(6):1046-58
   PubMed Web of Science ®Google Scholar
• Ou J, Tu H, Shan B, et al. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci USA 2001;98(11):6027-32
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Shimano H, Yahagi N, et al. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 2002;277(3):1705-11
   PubMed Web of Science ®Google Scholar
• Tamehiro N, Sato Y, Suzuki T, et al. Riccardin C: a natural product that functions as a liver X receptor (LXR)alpha agonist and an LXRbeta antagonist. FEBS Lett 2005;579(24):5299-304
   PubMed Web of Science ®Google Scholar
• Goldwasser J, Cohen PY, Yang E, et al. Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha. PLoS One 2010;5(8):e12399
   PubMed Web of Science ®Google Scholar
• Schultz JR, Tu H, Luk A, et al. Role of LXRs in control of lipogenesis. Genes Dev 2000;14(22):2831-8
   PubMed Web of Science ®Google Scholar
• Houck KA, Borchert KM, Hepler CD, et al. T0901317 is a dual LXR/FXR agonist. Mol Genet Metab 2004;83(1-2):184-7
   PubMed Web of Science ®Google Scholar
• Mitro N, Vargas L, Romeo R, et al. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR. FEBS Lett 2007;581(9):1721-6
   PubMed Web of Science ®Google Scholar
• Collins JL, Fivush AM, Watson MA, et al. Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J Med Chem 2002;45(10):1963-6
   PubMed Web of Science ®Google Scholar
• Joseph SB, McKilligin E, Pei L, et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA 2002;99(11):7604-9
   PubMed Web of Science ®Google Scholar
• Kaneko E, Matsuda M, Yamada Y, et al. Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist. J Biol Chem 2003;278(38):36091-8
   PubMed Web of Science ®Google Scholar
• Quinet EM, Savio DA, Halpern AR, et al. Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor. J Lipid Res 2004;45(10):1929-42
   PubMed Web of Science ®Google Scholar
• Katz A, Udata C, Ott E, et al. Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants. J Clin Pharmacol 2009;49(6):643-9
   PubMed Web of Science ®Google Scholar
• Yasuda T, Grillot D, Billheimer JT, et al. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol 2010;30(4):781-6
   PubMed Web of Science ®Google Scholar
• Viennois E, Mouzat K, Dufour J, et al. Selective liver X receptor modulators (SLiMs): what use in human health? Mol Cell Endocrinol 2012;351(2):129-41
   PubMed Web of Science ®Google Scholar
• Hong C, Tontonoz P. Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat Rev Drug Discov 2014;13(6):433-44
   PubMed Web of Science ®Google Scholar
• Jakobsson T, Treuter E, Gustafsson JA, et al. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends Pharmacol Sci 2012;33(7):394-404
   PubMed Web of Science ®Google Scholar
• Boergesen M, Pedersen TA, Gross B, et al. Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor alpha in mouse liver reveals extensive sharing of binding sites. Mol Cell Biol 2012;32(4):852-67
   PubMed Web of Science ®Google Scholar
• Pehkonen P, Welter-Stahl L, Diwo J, et al. Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages. BMC Genomics 2012;13:50
   PubMed Web of Science ®Google Scholar
• Carroll JS, Meyer CA, Song J, et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 2006;38(11):1289-97
   PubMed Web of Science ®Google Scholar
• Lin CY, Vega VB, Thomsen JS, et al. Whole-Genome Cartography of Estrogen Receptor alpha Binding Sites. PLoS Genet 2007;3(6):e87
   PubMed Web of Science ®Google Scholar
• Wang Q, Li W, Liu XS, et al. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell 2007;27(3):380-92
   PubMed Web of Science ®Google Scholar
• Derangere V, Chevriaux A, Courtaut F, et al. Liver X receptor beta activation induces pyroptosis of human and murine colon cancer cells. Cell Death Differ 2014;21(12):1914-24
   PubMed Web of Science ®Google Scholar
• Li X, Zhang S, Blander G, et al. SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell 2007;28(1):91-106
   PubMed Web of Science ®Google Scholar
• Lee JH, Park SM, Kim OS, et al. Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes. Mol Cell 2009;35(6):806-17
   PubMed Web of Science ®Google Scholar
• Peet DJ, Turley SD, Ma W, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998;93(5):693-704
   PubMed Web of Science ®Google Scholar
• Venkateswaran A, Repa JJ, Lobaccaro JM, et al. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J Biol Chem 2000;275(19):14700-7
   PubMed Web of Science ®Google Scholar
• Repa JJ, Berge KE, Pomajzl C, et al. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 2002;277(21):18793-800
   PubMed Web of Science ®Google Scholar
• Laffitte BA, Chao LC, Li J, et al. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci USA 2003;100(9):5419-24
   PubMed Web of Science ®Google Scholar
• Bonamassa B, Moschetta A. Atherosclerosis: lessons from LXR and the intestine. Trends Endocrinol Metab 2013;24(3):120-8
   PubMed Web of Science ®Google Scholar
• Kidani Y, Bensinger SJ. Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity. Immunol Rev 2012;249(1):72-83
   PubMed Web of Science ®Google Scholar
• Walcher D, Kummel A, Kehrle B, et al. LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes. Arterioscler Thromb Vasc Biol 2006;26(5):1022-8
   PubMed Web of Science ®Google Scholar
• Walcher D, Vasic D, Heinz P, et al. LXR activation inhibits chemokine-induced CD4-positive lymphocyte migration. Basic Res Cardiol 2010;105(4):487-94
   PubMed Web of Science ®Google Scholar
• Chang L, Zhang Z, Li W, et al. Liver-X-receptor activator prevents homocysteine-induced production of IgG antibodies from murine B lymphocytes via the ROS-NF-kappaB pathway. Biochem Biophys Res Commun 2007;357(3):772-8
   PubMed Web of Science ®Google Scholar
• Heine G, Dahten A, Hilt K, et al. Liver X receptors control IgE expression in B cells. J Immunol 2009;182(9):5276-82
   PubMed Web of Science ®Google Scholar
• Myhre AE, Agren J, Dahle MK, et al. Liver X receptor is a key regulator of cytokine release in human monocytes. Shock 2008;29(4):468-74
   PubMed Web of Science ®Google Scholar
• Venteclef N, Jakobsson T, Ehrlund A, et al. GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response. Genes Dev 2010;24(4):381-95
   PubMed Web of Science ®Google Scholar
• Smoak K, Madenspacher J, Jeyaseelan S, et al. Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense. J Immunol 2008;180(5):3305-12
   PubMed Web of Science ®Google Scholar
• Birrell MA, Catley MC, Hardaker E, et al. Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses. J Biol Chem 2007;282(44):31882-90
   PubMed Web of Science ®Google Scholar
• Valledor AF, Hsu LC, Ogawa S, et al. Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc Natl Acad Sci USA 2004;101(51):17813-18
   PubMed Web of Science ®Google Scholar
• Joseph SB, Bradley MN, Castrillo A, et al. LXR-Dependent Gene Expression Is Important for Macrophage Survival and the Innate Immune Response. Cell 2004;119(2):299-309
   PubMed Web of Science ®Google Scholar
• Solt LA, Kamenecka TM, Burris TP. LXR-mediated inhibition of CD4+ T helper cells. PLoS One 2012;7(9):e46615
   PubMed Web of Science ®Google Scholar
• Zelcer N, Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 2006;116(3):607-14
   PubMed Web of Science ®Google Scholar
• Hindinger C, Hinton DR, Kirwin SJ, et al. Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis. J Neurosci Res 2006;84(6):1225-34
   PubMed Web of Science ®Google Scholar
• Kim HJ, Fan X, Gabbi C, et al. Liver X receptor beta (LXRbeta): a link between beta-sitosterol and amyotrophic lateral sclerosis-Parkinson’s dementia. Proc Natl Acad Sci USA 2008;105(6):2094-9
   PubMed Web of Science ®Google Scholar
• Schmuth M, Jiang YJ, Dubrac S, et al. Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. J Lipid Res 2008;49(3):499-509
   PubMed Web of Science ®Google Scholar
• Schmuth M, Moosbrugger-Martinz V, Blunder S, et al. Role of PPAR, LXR, and PXR in epidermal homeostasis and inflammation. Biochim Biophys Acta 2014;1841(3):463-73
   PubMed Web of Science ®Google Scholar
• Li N, Rivera-Bermudez MA, Zhang M, et al. LXR modulation blocks prostaglandin E2 production and matrix degradation in cartilage and alleviates pain in a rat osteoarthritis model. Proc Natl Acad Sci USA 2010;107(8):3734-9
   PubMed Web of Science ®Google Scholar
• Asquith DL, Miller AM, Reilly J, et al. Simultaneous activation of the liver X receptors (LXRalpha and LXRbeta) drives murine collagen-induced arthritis disease pathology. Ann Rheum Dis 2011;70(12):2225-8
   PubMed Web of Science ®Google Scholar
• Zelcer N, Khanlou N, Clare R, et al. Attenuation of neuroinflammation and Alzheimer’s disease pathology by liver x receptors. Proc Natl Acad Sci USA 2007;104(25):10601-6
   PubMed Web of Science ®Google Scholar
• Koldamova RP, Lefterov IM, Staufenbiel M, et al. The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer’s disease. J Biol Chem 2005;280(6):4079-88
   PubMed Web of Science ®Google Scholar
• Treuter E, Venteclef N. Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation. Biochim Biophys Acta 2011;1812(8):909-18
   PubMed Web of Science ®Google Scholar
• Steffensen KR, Jakobsson T, Gustafsson JA. Targeting liver X receptors in inflammation. Expert Opin Ther Targets 2013;17(8):977-90
   PubMed Web of Science ®Google Scholar
• Venteclef N, Jakobsson T, Steffensen KR, et al. Metabolic nuclear receptor signaling and the inflammatory acute phase response. Trends Endocrinol Metab 2011;22(8):333-43
   PubMed Web of Science ®Google Scholar
• Traversari C, Sozzani S, Steffensen KR, et al. LXR-dependent and -independent effects of oxysterols on immunity and tumor growth. Eur J Immunol 2014;44(7):1896-903
   PubMed Web of Science ®Google Scholar
• Fukuchi J, Kokontis JM, Hiipakka RA, et al. Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res 2004;64(21):7686-9
   PubMed Web of Science ®Google Scholar
• Dufour J, Pommier A, Alves G, et al. Lack of liver X receptors leads to cell proliferation in a model of mouse dorsal prostate epithelial cell. PLoS One 2013;8(3):e58876
   PubMed Web of Science ®Google Scholar
• Fukuchi J, Hiipakka RA, Kokontis JM, et al. Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells. Cancer Res 2004;64(21):7682-5
   PubMed Web of Science ®Google Scholar
• Pommier AJ, Alves G, Viennois E, et al. Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene 2010;29(18):2712-23
   PubMed Web of Science ®Google Scholar
• Kim KH, Lee GY, Kim JI, et al. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity. J Lipid Res 2010;51(12):3425-33
   PubMed Web of Science ®Google Scholar
• Fu W, Yao J, Huang Y, et al. LXR agonist regulates the carcinogenesis of PCa via the SOCS3 Pathway. Cell Physiol Biochem 2014;33(1):195-204
   PubMed Web of Science ®Google Scholar
• Chuu CP, Chen RY, Hiipakka RA, et al. The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells. Biochem Biophys Res Commun 2007;357(2):341-6
   PubMed Web of Science ®Google Scholar
• Lee JH, Gong H, Khadem S, et al. Androgen deprivation by activating the liver X receptor. Endocrinology 2008;149(8):3778-88
   PubMed Web of Science ®Google Scholar
• Gong H, Guo P, Zhai Y, et al. Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol Endocrinol 2007;21(8):1781-90
   PubMed Web of Science ®Google Scholar
• Vedin LL, Lewandowski SA, Parini P, et al. The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis 2009;30(4):575-9
   PubMed Web of Science ®Google Scholar
• El Roz A, Bard JM, Huvelin JM, et al. LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast cancer cells: relation to proliferation and apoptosis. Anticancer Res 2012;32(7):3007-13
   PubMed Web of Science ®Google Scholar
• Nguyen-Vu T, Vedin LL, Liu K, et al. Liver x receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism. Breast Cancer Res 2013;15(3):R51
   PubMed Web of Science ®Google Scholar
• Steffensen KR, Robertson K, Gustafsson JA, et al. Reduced fertility and inability of oocytes to resume meiosis in mice deficient of the Lxr genes. Mol Cell Endocrinol 2006;256(1-2):9-16
   PubMed Web of Science ®Google Scholar
• El Roz A, Bard JM, Valin S, et al. Macrophage apolipoprotein E and proliferation of MCF-7 breast cancer cells: role of LXR. Anticancer Res 2013;33(9):3783-9
   PubMed Web of Science ®Google Scholar
• Rough JJ, Monroy MA, Yerrum S, et al. Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells. J Ovarian Res 2010;3:13
   PubMed Web of Science ®Google Scholar
• Uno S, Endo K, Jeong Y, et al. Suppression of beta-catenin signaling by liver X receptor ligands. Biochem Pharmacol 2009;77(2):186-95
   PubMed Web of Science ®Google Scholar
• Vedin LL, Gustafsson JA, Steffensen KR. The oxysterol receptors LXRalpha and LXRbeta suppress proliferation in the colon. Mol Carcinog 2013;52(11):835-44
   PubMedGoogle Scholar
• Lo Sasso G, Bovenga F, Murzilli S, et al. Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice. Gastroenterology 2013;144(7):1497-507
   PubMed Web of Science ®Google Scholar
• Candelaria NR, Addanki S, Zheng J, et al. Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells. PLoS One 2014;9(9):e106289
   PubMed Web of Science ®Google Scholar
• Troiani T, Martinelli E, Capasso A, et al. Targeting EGFR in pancreatic cancer treatment. Curr Drug Targets 2012;13(6):802-10
   PubMed Web of Science ®Google Scholar
• Pencheva N, Tran H, Buss C, et al. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 2012;151(5):1068-82
   PubMed Web of Science ®Google Scholar
• Pencheva N, Buss CG, Posada J, et al. Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation. Cell 2014;156(5):986-1001
   PubMed Web of Science ®Google Scholar
• Geyeregger R, Shehata M, Zeyda M, et al. Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes. J Leukoc Biol 2009;86(5):1039-48
   PubMed Web of Science ®Google Scholar
• Agarwal JR, Wang Q, Tanno T, et al. Activation of liver x receptors inhibits hedgehog signaling, clonogenic growth, and self-renewal in multiple myeloma. Mol Cancer Ther 2014;13(7):1873-81
   PubMed Web of Science ®Google Scholar
• Sanchez PV, Glantz ST, Scotland S, et al. Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors. Leukemia 2014;28(4):749-60
   PubMed Web of Science ®Google Scholar
• Gabbi C, Kim HJ, Barros R, et al. Estrogen-dependent gallbladder carcinogenesis in LXRbeta-/- female mice. Proc Natl Acad Sci USA 2010;107(33):14763-8
   PubMed Web of Science ®Google Scholar
• Sharma KL, Misra S, Kumar A, et al. Association of liver X receptors (LXRs) genetic variants to gallbladder cancer susceptibility. Tumour Biol 2013;34(6):3959-66
   PubMed Web of Science ®Google Scholar
• Guo D, Reinitz F, Youssef M, et al. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discov 2011;1(5):442-56
   PubMed Web of Science ®Google Scholar
• Noghero A, Perino A, Seano G, et al. Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2. Arterioscler Thromb Vasc Biol 2012;32(9):2280-8
   PubMed Web of Science ®Google Scholar
• Villablanca EJ, Raccosta L, Zhou D, et al. Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat Med 2010;16(1):98-105
   PubMed Web of Science ®Google Scholar
• Wang Q, Ma X, Chen Y, et al. Identification of interferon-gamma as a new molecular target of liver X receptor. Biochem J 2014;459(2):345-54
   PubMed Web of Science ®Google Scholar
• Nelson ER, Wardell SE, Jasper JS, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science 2013;342(6162):1094-8
   PubMed Web of Science ®Google Scholar
• Flaveny CA, Griffett K, El-Gendy BE, et al. Broad anti-tumor activity of a small molecule that selectively targets the warburg effect and lipogenesis. Cancer Cell 2015;28(1):42-56
   PubMed Web of Science ®Google Scholar